XtalPi Holdings Limited (HKG: 2228)

Market Cap	19.73B
Revenue (ttm)	211.77M
Net Income (ttm)	-2.73B
Shares Out	3.41B
EPS (ttm)	-4.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,973,000
Open	5.88
Previous Close	5.98
Day's Range	5.73 - 6.12
52-Week Range	3.05 - 16.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 4, 2025

About XtalPi Holdings

XtalPi Holdings Limited, an investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan. The company’s drug discovery solutions cover the whole drug discovery and research process, including target validation, hit identification, lead generation, lead optimization, and PCC nomination covering various modalities, which comprise small molecules, antibodies, peptides, ADC, and PROTAC. Its intelligent automation solutions focus on AI- and automation-enabled nov...

• Industry: Commercial Physical and Biological Research
• Founded: 2015
• Employees: 783
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2228

Financial Performance

In 2023, XtalPi Holdings's revenue was 174.42 million, an increase of 30.80% compared to the previous year's 133.35 million. Losses were -1.91 billion, 33.1% more than in 2022.

Financial numbers in CNY